Wu D, Wang SW, Lv M, Ji S, Li A. Y., Hydrogen sulfide in cancer: friend or foe? Nitric Oxide., 2015. 50: pp. 38–45.
Ascenção K, Lheimeur B, Szabo CJRB. Regulation of CyR61 expression and release by 3-mercaptopyruvate sulfurtransferase in colon cancer cells. Redox Biol. 2022;56:102466.
Article PubMed PubMed Central Google Scholar
Ma Y, et al. Anticancer effect of exogenous hydrogen sulfide in cisplatin–resistant A549/DDP cells. Oncol Rep. 2018;39(6):2969–77.
Shen Y, et al. Protective effects of hydrogen sulfide in hypoxic human umbilical vein endothelial cells: a possible mitochondria-dependent pathway. Int J Mol Sci. 2013;14(7):13093–108.
Article PubMed PubMed Central Google Scholar
Fahmy SA et al. Molecular engines, therapeutic targets, and challenges in Pediatric Brain tumors: a special emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery. Cancers (Basel), 2022. 14(21).
Youness RA et al. Role of Hydrogen Sulfide in Oncological and Non-oncological disorders and its regulation by non-coding RNAs: a Comprehensive Review. Noncoding RNA, 2024. 10(1).
Lee ZW, Chen ZJ, Zhao CS, Tan Y, Li CH, Moore L, Deng PK. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE. 2011;6(6):e21077.
Article CAS PubMed PubMed Central Google Scholar
Youness RA, et al. A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression. Nitric Oxide. 2018;80:12–23.
Article CAS PubMed Google Scholar
Li M, Deng LY, Pan Y, Fu L, Han H, Li X, Shi Y, Wang H. Therapeutic potential of endogenous hydrogen sulfide inhibition in breast cancer. Oncol Rep. 2021;45(5):1–9.
Wang L, Zhang SH, Zhang X, Liu X, Kang Y, Shi W, Wang X. I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3. Oncol Rep. 2019;41(1):427–36.
You J, Liang SX, Ye H, Wang J, Han L, Fang H, Kang H, Wang W. Cystathionine-γ-lyase promotes process of breast cancer in association with STAT3 signaling pathway. Oncotarget. 2017;8(39):65677.
Article PubMed PubMed Central Google Scholar
Dilek N, Toliver-Kinsky PA, Szabo T. Hydrogen sulfide: an endogenous regulator of the immune system. Pharmacol Res. 2020;161:105119.
Article CAS PubMed Google Scholar
Youness RA, et al. miR-4317, a novel tumor suppressor miRNA, alleviates immune-suppressive microenvironment induced by breast cancer. Ann Oncol. 2017;28:xi23.
Youness RA, et al. miR-4317, a promising player tuning the anti-tumor armamentarium against breast cancer. Ann Oncol. 2018;29:vi18–9.
Nafea H, et al. 60P curbing the interplay between mir-939-5p and HEIH lncRNA by EGCG represses hydrogen sulphide machinery and hinders breast cancer progression. Ann Oncol. 2020;31:S1235.
Coletta C, et al. Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S pathway: functional impairment by hyperglycemia and restoration by DL-alpha-lipoic acid. Mol Med. 2015;21(1):1–14.
Article CAS PubMed PubMed Central Google Scholar
Augsburger F, Szabo C. Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H(2)S) pathway in cancer cells. Pharmacol Res. 2020;154:104083.
Article CAS PubMed Google Scholar
Ascencao K et al. Sequential Accumulation of ‘Driver’ Pathway Mutations Induces the Upregulation of Hydrogen-Sulfide-Producing Enzymes in Human Colonic Epithelial Cell Organoids. Antioxid (Basel), 2022. 11(9).
Olah G, et al. Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation. Biochem Pharmacol. 2018;149:186–204.
Article CAS PubMed Google Scholar
Wrobel M, et al. Is development of high-grade gliomas sulfur-dependent? Molecules. 2014;19(12):21350–62.
Article PubMed PubMed Central Google Scholar
Szczesny B, et al. Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics. Sci Rep. 2016;6:36125.
Article CAS PubMed PubMed Central Google Scholar
Sogutdelen E, et al. Patterns of expression of H(2)S-Producing enzyme in human renal cell carcinoma specimens: potential Avenue for future therapeutics. Vivo. 2020;34(5):2775–81.
Meram AT, et al. Hydrogen sulfide is increased in oral squamous cell Carcinoma compared to adjacent benign oral mucosae. Anticancer Res. 2018;38(7):3843–52.
Article PubMed PubMed Central Google Scholar
Saurty-Seerunghen MS, et al. Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase. Cell Death Dis. 2022;13(10):913.
Article CAS PubMed PubMed Central Google Scholar
Rao SP et al. Role of 3-Mercaptopyruvate sulfurtransferase (3-MST) in physiology and disease. Antioxid (Basel), 2023. 12(3).
El Kilany FH, et al. miR-744/eNOS/NO axis: a novel target to halt triple negative breast cancer progression. Breast Dis. 2021;40(3):161–9.
Zhang Q, et al. The regulatory role of MiR-203 in oxidative stress induced cell injury through the CBS/H(2)S pathway. Nitric Oxide. 2022;118:31–8.
Article CAS PubMed Google Scholar
Mu T, et al. N1, N12-Diacetylspermine is elevated in Colorectal Cancer and promotes proliferation through the miR-559/CBS Axis in Cancer Cell lines. J Oncol. 2021;2021:6665704.
Article PubMed PubMed Central Google Scholar
Youness RA, et al. Targeting hydrogen sulphide signaling in breast cancer. J Adv Res. 2021;27:177–90.
Article CAS PubMed Google Scholar
Nafea H, et al. Dual targeting of H(2)S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by Mir-939-5p effectively curbs triple negative breast cancer. Heliyon. 2023;9(10):e21063.
Article CAS PubMed PubMed Central Google Scholar
Santos SS, Martins RL, Petrosino V, Zuhra M, Ascenção K, Anand K, Abdel-Kader A, Gad RM, Bourquin MZ, Szabo C. Role of Cystathionine β-Synthase and 3-Mercaptopyruvate sulfurtransferase in the regulation of Proliferation, Migration, and Bioenergetics of murine breast Cancer cells. Antioxid (Basel). 2023;12(3):647.
Abdel-Latif M, et al. MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer. Mol Cell Biochem. 2022;477(4):1281–93.
Article CAS PubMed Google Scholar
Abdallah RM, et al. Hindering the synchronization between mir-486-5p and H19 lncRNA by Hesperetin halts breast Cancer aggressiveness through tuning ICAM-1. Anticancer Agents Med Chem. 2022;22(3):586–95.
Article CAS PubMed Google Scholar
Awad AR, et al. An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR- 20a-MICA/B axis. Nat Prod Res. 2021;35(18):3126–30.
Article CAS PubMed Google Scholar
Mekky RY, et al. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer. Transl Oncol. 2023;31:101653.
Article CAS PubMed PubMed Central Google Scholar
SOLIMAN R-A, et al. Uncoupling tumor necrosis factor-α and interleukin-10 at tumor immune microenvironment of breast cancer through miR-17-5p/MALAT-1/H19 circuit. BIOCELL. 2022;46(3):769–83.
Selem NA, et al. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple negative breast Cancer through modulating PD-L1. Pathol Res Pract. 2023;248:154579.
Article CAS PubMed Google Scholar
Randi EB et al. Selenium-binding protein 1 (SELENBP1) supports hydrogen sulfide biosynthesis and Adipogenesis. Antioxid (Basel), 2021. 10(3).
El Din GS, et al. miRNA-506-3p directly regulates rs10754339 (A/G) in the Immune checkpoint protein B7-H4 in breast Cancer. Microrna. 2020;9(5):346–53.
Youssef SS, et al. miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with rs738409 polymorphism in PNPLA3. Per Med. 2022;19(6):483–93.
Article CAS PubMed Google Scholar
Nafea H, et al. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production. J Cell Physiol. 2021;236(7):5362–72.
Article CAS PubMed Google Scholar
Jassim GA, Hickey WD, Carter A. B., Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev, 2023(1).
Dent R, Trudeau HW, Rawlinson M, Sun E, Narod P. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat. 2009;115:423–8.
Krämer S, et al. Treatment progress in triple negative breast cancer. Eur J Gynaecol Oncol. 2022;43(2):341–52.
留言 (0)